Evidence map›Paper›PMID 29914930›Full record

ArticleInfection and immunity2018

Reduction of Articular and Systemic Inflammation by Kava-241 in a Porphyromonas gingivalis-Induced Arthritis Murine Model.

Olivier Huck, Jian You, Xianxian Han, Bin Cai, James Panek, Salomon Amar

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Opportunities and Challenges of Kava in Lung Cancer Prevention.International journal of molecular sciences · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Microorganisms · 2020
    Review
  8. Article
  9. Molecules (Basel, Switzerland) · 2019
    Review
  10. Article
  11. Article
  12. Pathogenesis of Important Virulence Factors ofFrontiers in cellular and infection microbiology · 2019
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Olivier HuckINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Strasbourg, France.ORCID https://orcid.org/0000-0002-7988-2290
Jian YouDepartment of Pharmacology, Department of Microbiology and Immunology, School of Medicine, New York Medical College, Valhalla, New York, USA.
Xianxian HanDepartment of Pharmacology, Department of Microbiology and Immunology, School of Medicine, New York Medical College, Valhalla, New York, USA.
Bin CaiDepartment of Chemistry, Boston University, Boston, Massachusetts, USA.
James PanekDepartment of Chemistry, Boston University, Boston, Massachusetts, USA.
Salomon AmarDepartment of Pharmacology, Department of Microbiology and Immunology, School of Medicine, New York Medical College, Valhalla, New York, USA salomon_amar@nymc.edu.ORCID https://orcid.org/0000-0002-0017-5930
New York Medical College · USBoston University · USInserm · FR

Funding

Role of LITAF in Inflammatory ProcessesR01DE014079 · NIDCR · NEW YORK MEDICAL COLLEGE · PI AMAR, SALOMON · 2002 to 2016
$5.4M
NIDCR NIH HHS R01 DE014079
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an inflammatory disease that has been linked to several risk factors, including periodontitis. Identification of new anti-inflammatory compounds to treat arthritis is needed. We had previously demonstrated the beneficial effect of Kava-241, a kavain-derived compound, in the management of

Indexed as

Porphyromonas gingivalisAnimalsAnti-Inflammatory AgentsArthritisBacteroidaceae InfectionsDisease Models, AnimalInflammationJointsLipopolysaccharidesMacrophagesMaleMiceOsteoclastsPyronesToll-Like Receptor 2Tumor Necrosis Factor-alphaAnti-Inflammatory AgentskavainLipopolysaccharidesPyronesTlr2 protein, mouseToll-Like Receptor 2Tumor Necrosis Factor-alphainfectioninflammationkavainperiodontitisTNF

Identifiers

PMID29914930
PMCPMC6105883
OpenAlexW2808801451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.